Source: BioPharma-Reporter

LabGenius: LabGenius utilising machine learning to 'transform' cancer treatment

LabGenius, which uses machine learning (ML) for antibody discovery, has presented data in a poster presentation at the Protein Engineering and Biotherapeutics (PEGS) annual meeting.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
James Field's photo - Founder & CEO of LabGenius

Founder & CEO

James Field

CEO Approval Rating

90/100

Read more